Hana Yamamoto

Iovance (IOVA) - A 2026 Play on TIL Commercialization and Margin Inflection

Autologous T-cell therapy near commercialization; improving revenue and gross-margin trends but high execution risk — tactical long for 2026.

Iovance is positioning to commercialize the first autologous tumor-infiltrating lymphocyte (TIL) therapy for solid tumors. Recent quarterly results sh...

Estados Unidos asigna $2.000 millones en ayuda humanitaria a Naciones Unidas

Compromiso menor refleja nuevos enfoques y recortes significativos en la asistencia internacional estadounidense

Estados Unidos ha comprometido 2.000 millones de dólares para ayuda humanitaria administrada por la ONU, una cifra que aunque es menor comparada con ...

Top Dividend-Paying Stocks to Consider for a $1,000 Investment

Examining ExxonMobil, Agree Realty, and Kimberly Clark as Reliable Sources of Growing Income

Investors seeking consistent income and potential growth can look to companies with a strong history of dividend increases. ExxonMobil, Agree Realty, ...

Building and Using Effective Stock Trading Checklists for Consistent and Disciplined Decisions

For beginner and intermediate traders learning how to create and implement trading checklists that improve decision-making, reduce errors, and enhance risk management

Trading checklists are powerful tools that bring structure and discipline to your stock market decisions by outlining clear steps and criteria before,...

Nvidia Integrates Groq Team and Technology to Strengthen AI Inferencing Capabilities

Strategic move includes licensing Groq's inference technology alongside key team hires, marking Nvidia's deeper entry into AI inference chips beyond GPUs

Nvidia has entered a non-exclusive licensing agreement with AI chip startup Groq, acquiring rights to its inference technology while also onboarding G...

Why Extreme Caution Is Advised Before Investing in Oklo

Examining the Valuation and Developmental Challenges of Oklo’s Nuclear Technology

Oklo stands out in 2025 as one of the most dynamic nuclear sector stocks, having surged over 275% this year. Despite the excitement surrounding its po...

Ondas Holdings Insider Executes Significant Option-Related Stock Sale

Director Jaspreet K. Sood Sells Nearly 30,000 Shares Following Option Exercise, Reflecting Routine Administrative Activity

On December 22, 2025, Ondas Holdings director Jaspreet K. Sood sold 29,698 shares of the company's stock, following the exercise of stock options. Thi...

Analyzing Year-End Market Dynamics: DBV Technologies and Hertz Global Holdings in Focus

A detailed look at promising biotech and mobility companies amid robust market shifts and seasonal trends

As the year concludes, equity markets have demonstrated a positive trajectory, supported by a seasonal Santa Claus rally and sector-specific performan...

Brookfield Wealth Engine: Misunderstood Upside at ~3.3% Yield

BAM's scale and cash-generation are underappreciated - actionable long trade with entry, stops and targets

Brookfield Asset Management runs one of the world’s largest alternative-asset platforms (USD 1.151 trillion AUM) and is showing back-to-back quarter...

Mineralys (MLYS) - Pre-NDA Momentum, Pivotal 2026 Optionality; Tactical Long with a High-Risk Payoff

Lorundrostat data and fresh financing create a multi-quarter runway into regulatory readouts — trade idea for a position-sized long.

Mineralys has taken lorundrostat through pivotal testing in uncontrolled and resistant hypertension, published late-breaking data across 2025, and rei...